150 related articles for article (PubMed ID: 26183647)
1. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia.
Salvianti F; Inversetti A; Smid M; Valsecchi L; Candiani M; Pazzagli M; Cremonesi L; Ferrari M; Pinzani P; Galbiati S
Placenta; 2015 Sep; 36(9):996-1001. PubMed ID: 26183647
[TBL] [Abstract][Full Text] [Related]
2. RASSF1A in maternal plasma as a molecular marker of preeclampsia.
Papantoniou N; Bagiokos V; Agiannitopoulos K; Kolialexi A; Destouni A; Tounta G; Kanavakis E; Antsaklis A; Mavrou A
Prenat Diagn; 2013 Jul; 33(7):682-7. PubMed ID: 23526657
[TBL] [Abstract][Full Text] [Related]
3. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
[TBL] [Abstract][Full Text] [Related]
4. Maternal plasma cell-free DNA in the prediction of pre-eclampsia.
Rolnik DL; O'Gorman N; Fiolna M; van den Boom D; Nicolaides KH; Poon LC
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):106-11. PubMed ID: 25252010
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of placenta-derived RASSF1A sequence expression in maternal plasma for pre-eclampsia].
Wang J; Yang J; Wu X; Mu Y; Li S; Cui K; Wang X; Zhao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):25-8. PubMed ID: 24510557
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
[TBL] [Abstract][Full Text] [Related]
7. Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes.
Poon LC; Musci T; Song K; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2013; 33(4):215-23. PubMed ID: 23466432
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein.
Saraswathy S; Sahai K; Yadav TP; Arora D; Mendiratta SL; Naqvi SH; Biswas S; Krishnan M; Abraham KM
Pregnancy Hypertens; 2016 Oct; 6(4):306-312. PubMed ID: 27939474
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative detection of the hypermethylated RASSF1A gene in maternal plasma of pre-eclampsia].
Wang J; Zhao F; Wu Y; Liu R; Mu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):73-6. PubMed ID: 20140873
[TBL] [Abstract][Full Text] [Related]
10. Cell-free fetal DNA in maternal circulation after chorionic villous sampling.
Di Tommaso M; Seravalli V; Salvianti F; Bussani C; Pasquini L; Cordisco A; Pinzani P
Prenat Diagn; 2013 Jul; 33(7):695-9. PubMed ID: 23658144
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
[TBL] [Abstract][Full Text] [Related]
12. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia.
Tsui DW; Chan KC; Chim SS; Chan LW; Leung TY; Lau TK; Lo YM; Chiu RW
Prenat Diagn; 2007 Dec; 27(13):1212-8. PubMed ID: 17994635
[TBL] [Abstract][Full Text] [Related]
13. Fetal-specific hypermethylated RASSF1A quantification in pregnancy.
Saraswathy S; Sahai K; Arora D; Krishnan M; Mendiratta SL; Biswas S; Abraham KM
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):849-853. PubMed ID: 27165812
[TBL] [Abstract][Full Text] [Related]
14. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis.
Yi P; Yin N; Zheng Y; Jiang H; Yu X; Yan Y; Liu Q; Xiao F; Li L
Cell Biochem Biophys; 2013; 67(3):977-81. PubMed ID: 23579583
[TBL] [Abstract][Full Text] [Related]
16. Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma.
Zhao F; Wang J; Liu R; Yang J; Cui K; Wu Y; Guo J; Mu Y; Wang X
Prenat Diagn; 2010 Aug; 30(8):778-82. PubMed ID: 20661892
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.
Zhang L; Wang CM; Zhou WP; Chen QP; Zhou S; Lei W; Deng H; Zhang L; Liu GC
Reprod Sci; 2021 Apr; 28(4):1194-1199. PubMed ID: 33417202
[TBL] [Abstract][Full Text] [Related]
18. Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.
Amaral LM; Sandrim VC; Kutcher ME; Spradley FT; Cavalli RC; Tanus-Santos JE; Palei AC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429954
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric analysis of cell-free DNA in melanoma patients.
Salvianti F; Pinzani P; Verderio P; Ciniselli CM; Massi D; De Giorgi V; Grazzini M; Pazzagli M; Orlando C
PLoS One; 2012; 7(11):e49843. PubMed ID: 23209607
[TBL] [Abstract][Full Text] [Related]
20. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
